Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions
Melanoma
Interventions
BIOLOGICAL

Lipo-MERIT

vaccination

Trial Locations (4)

55131

Universitätsmedizin Mainz, Hautklinik und Poliklinik, Mainz

60590

Johann Wolfgang Goethe Universität Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie, Frankfurt

68167

Universitätsmedizin Mannheim, Klinik für Dermatologie, Venerologie und Allergologie, Mannheim

69120

Universität Heidelberg, Dermatologie und NCT, Heidelberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioNTech SE

INDUSTRY